#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hyperinsulinism Basal cell naevus syndrome Acute hepatic failure Amyotrophic lateral sclerosis Microvillous inclusion disease Huntington's disease Chronic lymphocytic leukaemia recurrent Burkitt's lymphoma refractory Extra-osseous Ewing's sarcoma Epstein-Barr virus associated lymphoproliferative disorder Trigeminal neuralgia Crigler-Najjar syndrome Acute graft versus host disease in liver Immunodeficiency Essential thrombocythaemia More trials…

    Learn about Rare Diseases

    Hepatic angiosarcoma – Treatment Osteosarcoma recurrent – Basic Information Paroxysmal nocturnal haemoglobinuria Methylmalonic acidaemia – Trials in Disease Retinitis pigmentosa – Basic Information X-linked lymphoproliferative syndrome – Treatment Angelman’s syndrome Alport’s syndrome Antithrombin III deficiency Pelizaeus-Merzbacher disease – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Quemliclustat Benzalkonium Chloride Ropivacaine Hydrochloride Pitavastatin Calcium Daunorubicin Flupentixol Decanoate Taletrectinib ASP3082 VX-407 Thiamine Hydrochloride At-1501 RIVASTIGMINE Ttf-Ngr Lutropin Alfa Platelet Concentrate Sodium Glycocholate Nimotuzumab Teclistamab Indapamide IDROXIOLEIC ACID More therapies…

    Learn about Your Condition

    Wiskott-Aldrich syndrome Perthes disease Erythema IgA nephropathy Piriformis syndrome Apheresis Myelofibrosis Candida infection Hyperparathyroidism secondary Oesophageal disorder Skin ulcer Triple positive breast cancer Inguinal hernia Coronary artery disease Morning sickness More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Mental Disorders

  • Study on Thiopental Sodium Dose During Electroconvulsive Therapy for Patients with Major Depressive Disorder

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Thiopental Sodium
    Sweden

  • Study of Psilocybin for Patients with Treatment-Resistant Depression

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Depression
    Investigated Drugs:
    • Psilocybine
    Austria

  • Study on the Effects of Minocycline on Inflammation in Patients with Depression

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Minocycline Hydrochloride
    Italy

  • Study on the Effectiveness of Calcium Folinate, Omega-3-Acid Ethyl Esters, and Cyanocobalamin for Patients at High Risk of Psychosis or Experiencing First Episode Psychosis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Psychotic disorder
    Investigated Drugs:
    • Acetylcysteine
    • OMEGA-3-ACID ETHYL ESTERS 90
    • Cyanocobalamin
    France

  • Study on Vitamin D for Patients with Depression or Bipolar Disorder

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Bipolar disorder
    • Depression
    Investigated Drugs:
    • Colecalciferol
    Italy

  • Study on the Effects of Escitalopram, Paroxetine, and Naltrexone for Patients with Compulsive Sexual Behavior Disorder

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Compulsive sexual behaviour
    Investigated Drugs:
    • Escitalopram Oxalate
    • Naltrexone Hydrochloride
    • Paroxetine
    Poland
Previous Page
1 … 25 26 27 28 29 … 40
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!